Chengcheng Fu

6PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone.

Hongying You, Weiqin Yao, Lingzhi Yan

|Jul 02, 2025
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Yanlei Gong, Tingting Tao, Mo Zhou

|Feb 26, 2025
Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial.

Xiang Zhang, Yue Han, Huiying Qiu

|Jan 12, 2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairment.

Yingying Zhai, Lingzhi Yan, Song Jin

|Oct 14, 2022
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.

Yifan Zhai, Qiuqiong Tang, Douglas D Fang

|Feb 03, 2022
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma.

Xiaolan Shi, Lingzhi Yan, Jingjing Shang

Pageof 1

Frequent Collaborators

2 joint publications

Lingzhi Yan

2 joint publications

Shengli Xue

1 joint publications

Xiaolan Shi

1 joint publications

Yifan Zhai